Skip to main navigation
Skip to content
Skip to content
PDL Logo Blue Green
  • About PDL
  • Leadership
  • Investor Relations
  • About PDL
    • Management
  • Portfolio of Assets
  • Investor Relations
  • News
  • Contact

SEC Filings

PDL  > Investor Relations > SEC Filings

SEC Filings

Filing date Form Description View
Jul 28, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0000882104-20-000104.pdf
0000882104-20-000104.xls
Jul 17, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0000882104-20-000102.pdf
0000882104-20-000102.xls
Jul 8, 2020 UPLOAD

UPLOAD

View HTML
Jul 7, 2020 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
0000882104-20-000100.pdf
0000882104-20-000100.xls
Jul 2, 2020 CORRESP

CORRESP

View HTML
0000882104-20-000098.xls
Jul 2, 2020 UPLOAD

UPLOAD

View HTML
Jun 30, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0000882104-20-000094.pdf
0000882104-20-000094.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Jun 30, 2020 PRER14A

Proxy soliciting materials. Revised preliminary material

View HTML
0000882104-20-000096.pdf
0000882104-20-000096.xls
Jun 23, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0000882104-20-000083.pdf
0000882104-20-000083.xls
Jun 5, 2020 PRER14A

Proxy soliciting materials. Revised preliminary material

View HTML
0000882104-20-000081.pdf
0000882104-20-000081.xls
May 26, 2020 SC 13D/A

An amendment to a SC 13D filing

View HTML
0001193125-20-151580.pdf
0001193125-20-151580.xls
May 26, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0000899243-20-014185.pdf
0000899243-20-014185.xls
May 21, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0000882104-20-000075.pdf
0000882104-20-000075.xls
May 18, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0000882104-20-000073.pdf
0000882104-20-000073.xls
May 11, 2020 10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
0000882104-20-000071.pdf
0000882104-20-000071.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

    Investor Relations

    • Frequently Asked Questions (FAQ)
    • Investor Updates
    • Press Releases
    • 2020 Proxy Statement
    • Tax Information
      • Common Stock Tax Information
      • Convertible Note Tax Information
    • SEC Filings
    • Contact Information

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • RSS
    • Print
    • Share
    • Search
    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS

PDL Logo White Fill

  • Terms of Use
  • Sitemap
© Copyright 2021 PDL BioPHARMA. All Rights Reserved.